FDA — authorised 21 September 2006
- Application: NDA021994
- Marketing authorisation holder: SANDOZ
- Status: supplemented
FDA authorised Travatan on 21 September 2006
Yes. FDA authorised it on 21 September 2006; FDA has authorised it.
SANDOZ holds the US marketing authorisation.